Connection
Wells Messersmith to Neoplasms, Second Primary
This is a "connection" page, showing publications Wells Messersmith has written about Neoplasms, Second Primary.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.175 |
|
|
|
-
Meric-Bernstam F, Sweis RF, Hodi FS, Messersmith WA, Andtbacka RHI, Ingham M, Lewis N, Chen X, Pelletier M, Chen X, Wu J, McWhirter SM, M?ller T, Nair N, Luke JJ. Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas. Clin Cancer Res. 2022 02 15; 28(4):677-688.
Score: 0.175